Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 51.9
(0.31%)
CNY 51.9
(0.31%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.54 Billion CNY | 40.64% |
| 2022 | 2.52 Billion CNY | 18.59% |
| 2021 | 2.12 Billion CNY | 52.4% |
| 2020 | 1.39 Billion CNY | 12.14% |
| 2019 | 1.24 Billion CNY | 18.43% |
| 2018 | 1.05 Billion CNY | 71.86% |
| 2017 | 611.47 Million CNY | 281.9% |
| 2016 | 160.11 Million CNY | -18.59% |
| 2015 | 196.66 Million CNY | 29.75% |
| 2014 | 151.57 Million CNY | -9.13% |
| 2013 | 166.8 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.71 Billion CNY | 4.85% |
| 2024 Q3 | 4.44 Billion CNY | 10.64% |
| 2024 Q2 | 4.01 Billion CNY | 7.96% |
| 2023 FY | 3.54 Billion CNY | 40.64% |
| 2023 Q2 | 2.61 Billion CNY | 0.95% |
| 2023 Q3 | 2.91 Billion CNY | 11.31% |
| 2023 Q4 | 3.54 Billion CNY | 21.76% |
| 2023 Q1 | 2.59 Billion CNY | 2.79% |
| 2022 Q3 | 2.37 Billion CNY | 3.13% |
| 2022 Q2 | 2.3 Billion CNY | 6.84% |
| 2022 Q1 | 2.15 Billion CNY | 1.42% |
| 2022 FY | 2.52 Billion CNY | 18.59% |
| 2022 Q4 | 2.52 Billion CNY | 6.13% |
| 2021 Q4 | 2.12 Billion CNY | 4.94% |
| 2021 Q1 | 1.39 Billion CNY | -0.36% |
| 2021 FY | 2.12 Billion CNY | 52.4% |
| 2021 Q3 | 2.02 Billion CNY | 3.03% |
| 2021 Q2 | 1.96 Billion CNY | 41.47% |
| 2020 FY | 1.39 Billion CNY | 12.14% |
| 2020 Q4 | 1.39 Billion CNY | 3.65% |
| 2020 Q3 | 1.34 Billion CNY | 0.38% |
| 2020 Q2 | 1.34 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q3 | 1.16 Billion CNY | 8.38% |
| 2019 Q2 | 1.07 Billion CNY | 7.2% |
| 2019 Q4 | 1.24 Billion CNY | 6.63% |
| 2019 FY | 1.24 Billion CNY | 18.43% |
| 2019 Q1 | 1 Billion CNY | -4.42% |
| 2018 Q2 | 751.66 Million CNY | 2.34% |
| 2018 Q1 | 734.46 Million CNY | 20.36% |
| 2018 FY | 1.05 Billion CNY | 71.86% |
| 2018 Q4 | 1.05 Billion CNY | 4.1% |
| 2018 Q3 | 1 Billion CNY | 34.3% |
| 2017 FY | 611.47 Million CNY | 281.9% |
| 2017 Q4 | 610.24 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q4 | 160.2 Million CNY | 0.0% |
| 2016 Q2 | 169.98 Million CNY | 0.0% |
| 2016 Q3 | 160.2 Million CNY | -5.75% |
| 2016 FY | 160.11 Million CNY | -18.59% |
| 2016 Q1 | 169.98 Million CNY | -13.57% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 196.66 Million CNY | 0.0% |
| 2015 FY | 196.66 Million CNY | 29.75% |
| 2015 Q3 | 196.66 Million CNY | 0.0% |
| 2014 FY | 151.57 Million CNY | -9.13% |
| 2013 FY | 166.8 Million CNY | 0.0% |